Becton DickinsonBDX +2.44%76 Market Cap is $41,711 Mil as of Jun. 25, 2026. GuruFocus rates BDX with a GF Score™ of 76/100 and a GF Value™ of $191.05 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Becton Dickinson ranks better than 98.85% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Becton Dickinson's share price for the quarter that ended in Mar. 2026 was $157.23. Becton Dickinson's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 276 Mil. Therefore, Becton Dickinson's market cap for the quarter that ended in Mar. 2026 was $43,323 Mil.
Becton Dickinson's quarterly market cap
increased
from Sep. 2025 ($42,008 Mil) to Dec. 2025 ($43,456 Mil) but then
declined
from Dec. 2025 ($43,456 Mil) to Mar. 2026 ($43,323 Mil).
Becton Dickinson's annual market cap
declined
from Sep. 2023 ($59,039 Mil) to Sep. 2024 ($54,814 Mil) and
declined
from Sep. 2024 ($54,814 Mil) to Sep. 2025 ($42,008 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Becton Dickinson's Enterprise Value for Today is $58,174 Mil.
Becton Dickinson (NYSE:BDX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Becton Dickinson Market Cap Related Terms
Becton Dickinson Market Cap Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton Dickinson's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Market Cap distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Becton Dickinson's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (BDX) has a Market Cap of $41,711 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Becton Dickinson and its competitors. According to the industry distribution chart, Becton Dickinson ranks #10 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is Becton Dickinson's Market Cap too high?
Becton Dickinson's current Market Cap is $41,711 Mil. The Medical Devices & Instruments industry median Market Cap is 122.56. Becton Dickinson's value of $41,711 Mil is 33933.7% above this industry median. Based on the distribution chart, Becton Dickinson ranks #10 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Market Cap compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #10 out of 866 companies for Market Cap. This places Becton Dickinson in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 122.56. Becton Dickinson's value of $41,711 Mil is 33933.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.56, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton Dickinson's current Market Cap of $41,711 Mil is 33933.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Becton Dickinson and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current Market Cap is $41,711 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $191.05, compared to a current price of $151.38 — trading 20.8% below its estimated fair value. The current Market Cap is $41,711 Mil and 33933.7% above the Medical Devices & Instruments industry median of 122.56. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Becton Dickinson (BDX), the current Market Cap is $41,711 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of $151.38 is trading 20.8% below its estimated GF Value™ of $191.05.
GuruFocus considers Becton Dickinson to be Modestly Undervalued.
Key valuation signals for BDX:
Market Cap: $41,711 Mil
GF Value™: $191.05 vs. price of $151.38 (20.8% below fair value)
Industry Position: 33933.7% above the Medical Devices & Instruments median (#10 of 866)
No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score
Get the complete analysis for BDX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDX has been successfully added to your 
